mailed
on 30 Jan 2024
Last Applicant/ Owned by
12555 High Bluff Dr., Suite 300
San Diego
CA
92130
Serial Number
97639433 filed on 19th Oct 2022
Registration Number
N/A
Correspondent Address
Barry F. Soalt PROCOPIO CORY HARGREAVES & SAVITCH LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical product development services; Pharmaceutical research services "BIOVENTURES" Pharmaceutical products for the treatment of viral and infectious diseases, allergies, diabetes; and, for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointRead More
Pharmaceutical product development services; Pharmaceutical research services
11th 000101
11th 000101
Pharmaceutical products for the treatment of viral and infectious diseases, allergies, diabetes; and, for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood, weight, pregnancy and immune system related diseases and disorders, all for the purpose of integrating digital and biopharmaceutical therapeutics to increase health-span and life-span for all humanity
11th 000101
11th 000101
No 97639433
No Service Mark
No 11819901US03
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 30th Apr 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 29th Apr 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 29th Apr 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 05th Feb 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 05th Feb 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 05th Feb 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 05th Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 30th Jan 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 30th Jan 2024 | FINAL REFUSAL E-MAILED |
| 30th Jan 2024 | FINAL REFUSAL WRITTEN |
